Skip to main content
Premium Trial:

Request an Annual Quote

Critical Path, Hamner Institutes Ink Biomarker Pact

NEW YORK (GenomeWeb News) – Critical Path Institute (C-Path) and The Hamner Institutes for Health Sciences have signed a memorandum of understanding to collaborate on finding markers for monitoring drug-induced liver injury.

The non-profit research organizations plan to collaborate on regulatory science research for predicting, detecting, and monitoring liver safety issues during the development of new medicines. They said a goal of the collaboration is to generate data and reach scientific consensus for biomarkers and other methods that would be submitted to the US Food and Drug Administration to be qualified for specific uses in product development.

"It is imperative that we continue to build important synergies to support cutting-edge research that ultimately translates to getting safer, more effective medicines into the hands of patients," Raymond Woolsey, president and CEO of Tucson, Ariz.-based C-Path.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.